Manuscript Objectives: In this publication, our expect teams analyzes patient experience parameters and the associated...
Our Vision and Mission
To collaboratively advance and transform patient care and improve patient outcomes by leading fundamental advancements in subcutaneous drug development and delivery in a precompetitive manner.
-
Improve subcutaneous drug development and delivery
-
We can expand subcutaneous technology toolbox
Join the Experts!
Unlocking Opportunities for Growth and Success
Prioritized Opportunities / Problem Statements
The Subcutaneous Drug Development & Delivery Consortium developed the top 6 problem statements that will be prioritized:
Get Involved
In order to continue the Subcutaneous Drug Development & Delivery Consortium’s momentum into 2022, we hope to engage individuals and organizations interested in participating and benefiting from pre-competitive collaborations centered around addressing subcutaneous industry issues critical to all members.
Consortium members are:
- A diverse group of key members of the subcutaneous community (i.e., industry, academia, regulatory, payers, etc.)
- Collaborating to advance the most pressing issues and opportunities in subcutaneous dosage and delivery in a precompetitive manner
- Key decision makers within their organizations
Find the latest resources and publications
Manuscript Objectives: Subject Matter Experts from the Subcutaneous Drug Development & Delivery Consortium review...
Manuscript Objectives: Review the challenges and opportunities for SC delivery of high dose/volume biologics Consider…
Stay up-to-date with the latest news and events
Get in touch with us!
Your inquiries matter, and we’re here to respond with precision and care.
Submit the form to contact the Subcutaneous Drug Development & Delivery Consortium.
© 2024 Subcutaneous Drug Development & Delivery Consortium
English